ES2167743T3 - Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias. - Google Patents

Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias.

Info

Publication number
ES2167743T3
ES2167743T3 ES97922236T ES97922236T ES2167743T3 ES 2167743 T3 ES2167743 T3 ES 2167743T3 ES 97922236 T ES97922236 T ES 97922236T ES 97922236 T ES97922236 T ES 97922236T ES 2167743 T3 ES2167743 T3 ES 2167743T3
Authority
ES
Spain
Prior art keywords
treatment
pirimidil
piperazinas
piridil
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97922236T
Other languages
English (en)
Inventor
Anders Bjork
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum AB filed Critical Biovitrum AB
Application granted granted Critical
Publication of ES2167743T3 publication Critical patent/ES2167743T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE EXPONE EL USO DE UN COMPUESTO DE FORMULA (I) Y DE LAS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES DEL MISMO, EN DONDE R1 ES UN HALOGENO O HIDROGENO, Y R2 ES UN HALOGENO; X ES CH 2 , O S; R3 Y R4 SON IGUALES O DIFERENTES, Y SE ELIGEN ENTRE EL HIDROGENO O UN ALQUILO INFERIOR; N ES 2 O 3; A SE SELECCIONA EN LOS GRUPOS (A), (B) O (C) DE PIRIMIDILO O PIRIDILO, EN DONDE R5, R6 Y R7 SON TAL COMO SE DEFINEN EN LA MEMORIA. SE EXPONE IGUALMENTE LA FABRICACION DE UN MECANISMO PARA EL ALIVIO O PREVENCION DEL SINDROME DE ABSTINENCIA RESULTANTE DE LA ADICCION A UNA DROGA O EL ABUSO DE SUSTANCIAS O PARA SU TRATAMIENTO.
ES97922236T 1996-05-06 1997-04-22 Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias. Expired - Lifetime ES2167743T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601708A SE9601708D0 (sv) 1996-05-06 1996-05-06 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders

Publications (1)

Publication Number Publication Date
ES2167743T3 true ES2167743T3 (es) 2002-05-16

Family

ID=20402456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97922236T Expired - Lifetime ES2167743T3 (es) 1996-05-06 1997-04-22 Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias.

Country Status (20)

Country Link
US (1) US6221858B1 (es)
EP (1) EP0900082B1 (es)
JP (1) JP2000509711A (es)
CN (1) CN1111408C (es)
AT (1) ATE208197T1 (es)
AU (1) AU704695B2 (es)
BR (1) BR9708922A (es)
CA (1) CA2253473A1 (es)
CZ (1) CZ291107B6 (es)
DE (1) DE69708084T2 (es)
DK (1) DK0900082T3 (es)
ES (1) ES2167743T3 (es)
HU (1) HUP9902802A3 (es)
IL (1) IL126795A (es)
NO (1) NO316611B1 (es)
NZ (1) NZ332484A (es)
PT (1) PT900082E (es)
RU (1) RU2197245C2 (es)
SE (1) SE9601708D0 (es)
WO (1) WO1997041858A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE491689T1 (de) 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
FR2827172B1 (fr) * 2001-07-13 2004-07-02 Pf Medicament Derives de pyridin-2-yl-methylamine pour le traitement de la dependance aux opioides
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299928A (en) 1980-03-14 1981-11-10 Mobay Chemical Corporation Impact modified polycarbonates
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders

Also Published As

Publication number Publication date
HUP9902802A3 (en) 2002-01-28
DE69708084D1 (de) 2001-12-13
EP0900082A1 (en) 1999-03-10
CZ291107B6 (cs) 2002-12-11
DE69708084T2 (de) 2002-06-06
CN1111408C (zh) 2003-06-18
NO985063L (no) 1999-01-05
CZ355998A3 (cs) 1999-06-16
RU2197245C2 (ru) 2003-01-27
WO1997041858A1 (en) 1997-11-13
SE9601708D0 (sv) 1996-05-06
IL126795A (en) 2003-05-29
PT900082E (pt) 2002-04-29
NO985063D0 (no) 1998-10-30
AU704695B2 (en) 1999-04-29
CN1223583A (zh) 1999-07-21
HUP9902802A2 (hu) 2000-05-28
ATE208197T1 (de) 2001-11-15
BR9708922A (pt) 1999-08-03
NO316611B1 (no) 2004-03-08
AU2796097A (en) 1997-11-26
CA2253473A1 (en) 1997-11-13
JP2000509711A (ja) 2000-08-02
US6221858B1 (en) 2001-04-24
EP0900082B1 (en) 2001-11-07
IL126795A0 (en) 1999-08-17
DK0900082T3 (da) 2002-02-18
NZ332484A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
SE9504661D0 (sv) New compounds
BR9709823A (pt) Amidas de piridil alqueno-e priridil alquino-ácido como citostáticos e imuno-supressores
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
MY107157A (en) Quinuclidine derivatives.
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
BR9506847A (pt) Composto composição farmacêutica uso de um composto processo para o tratamento da dor
SE9702564D0 (sv) New compounds
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
ES2058596T3 (es) Empleo de derivados de l-carnitina en el tratamiento terapeutico de alteraciones degenerativas del sistema nervioso.
ES2167743T3 (es) Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias.
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
SE9504662D0 (sv) New compounds
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
TH32887A (th) สารประกอบทางเคมี
ES2169471T3 (es) Derivados de la tetrahidroimidazo(2,1-a)isoquinolina.
ECSP951595A (es) Derivados de pirrol case ran 4070/101
TH24392A (th) อนุพันธ์ 3-เฟนิลไอโซควินอล-1(2h)-โอน การเตรียมและการใช้ในยาที่มีใช้รักษา
DE3689086T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzung und ihre Verwendung.
IT1257884B (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.